Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)

NCT02475122 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT02475122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02475122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
December 31, 2020
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding esophageal varices, cirrhosis